NCT03786952

Brief Summary

The impact of well-known risk factors for such disorders (stress, biological sex, anxiety-related dispositions) on fear generalization will be examined. Findings from this study may provide insight into how these risk factors influence the development and/or maintenance of psychological disorders that involve overgeneralization of fear and could facilitate future approaches to their treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
606

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 18, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 26, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

January 25, 2019

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
9 months until next milestone

Results Posted

Study results publicly available

March 23, 2023

Completed
Last Updated

March 23, 2023

Status Verified

February 1, 2023

Enrollment Period

3.4 years

First QC Date

December 18, 2018

Results QC Date

December 16, 2022

Last Update Submit

February 23, 2023

Conditions

Keywords

stresssexfeargeneralizationcortisolalpha-amylaseestradiolprogesterone

Outcome Measures

Primary Outcomes (6)

  • Fear-potentiated Startle Responses to the CS+ and CS- During Acquisition

    Peak eyeblink startle responses 20-200 ms following presentation of a startle probe were measured. Startle responses were assessed for each of 3 trial types: (1) following the startle probe alone \[noise alone (NA) trials\], (2) following the CS+ and startle probe (CS+ trials), and (3) following the CS- and startle probe (CS- trials). Participants were exposed to 16 blocks of trials, and each block included 1 presentation of each trial type. During the last 12 blocks, CS+ trials also included the presentation of an aversive US. For each block, startle responses to NA trials were subtracted from startle responses to CS+ trials and from startle responses to CS- trials to create 2 separate fear-potentiated startle response measures: 1 for the CS+ and 1 for the CS-. Average fear-potentiated startle responses to the CS+ and CS- during the last 4 blocks of trials were used as an indicator of fear learning (greater responses to the CS+, relative to the CS-, indicated greater learning).

    Average of the responses from trial block 13, trial block 14, trial block 15, and trial block 16 on Day 1

  • EMG Responses to CS+, CS-, and Generalization Stimuli During Generalization Testing

    Peak eyeblink startle responses 20-200 ms following the presentation of a startle probe were measured. Startle responses were assessed for each of 10 trial types: (1) following the startle probe alone \[noise alone (NA) trials\], (2) following the CS+ and startle probe (CS+ trials), (3) following each of 7 generalization stimuli and startle probe (GS trials), and (4) following the CS- and startle probe (CS- trials). Participants were exposed to 3 blocks of trials, and each block included 1 presentation of each trial type. For each block, startle responses to the NA trials were subtracted from startle responses to the CS+, GSs, and CS- trials to create separate fear-potentiated startle response measures for each of the 9 different stimuli. Average fear-potentiated startle responses to each stimulus across all 3 blocks were used as an indicator of fear expression. Greater scores for the generalization stimuli (GS) indicated a greater generalization of fear.

    Average of responses from all trials on Day 2

  • Skin Conductance Responses to CS+ and CS- During Acquisition

    Electrodermal activity was measured following presentation of the CS+ and CS- during acquisition on Day 1. Participants were exposed to 16 blocks of trials, with each block including a single presentation of each stimulus. During the last 12 blocks, CS+ trials included the presentation of an aversive US. For each block, skin conductance responses were quantified by calculating the average increase in electrodermal activity (from a 1 s pre-stimulus baseline) 3-6 s after CS+ or CS- onset. Average skin conductance responses to the CS+ and CS- during the last 4 blocks of trials were used as an indicator of fear learning (greater responses to the CS+, relative to the CS-, indicated greater learning).

    Average of the responses from trial block 13, trial block 14, trial block 15, and trial block 16 on Day 1

  • Skin Conductance Responses to CS+, Generalization Stimuli, and CS- During Generalization Testing

    Electrodermal activity was measured following presentation of the CS+, 7 generalization stimuli (GSs), and CS- during generalization testing on Day 2. Participants were exposed to 3 blocks of trials, with each block including a single presentation of each stimulus. For each block, skin conductance responses were quantified by calculating the average increase in electrodermal activity (from a 1 s pre-stimulus baseline) 3-6 s after onset of the CS+, 7 GSs, or CS- onset.. Average skin conductance responses to each stimulus across all 3 blocks were used as an indicator of fear expression. Greater scores for the generalization stimuli (GS) indicated a greater generalization of fear.

    Average of responses from all trials on Day 2

  • US Expectancy Ratings to CS+ and CS- During Acquisition

    Participants were exposed to 16 blocks of trials, and each block included 1 presentation of the CS+ and one presentation of the CS-. During the last 12 blocks, CS+ trials included the presentation of an aversive US. During each trial, participants pressed, within 3 seconds of stimulus onset, a button marked "+" if they expected the stimulus to be followed by the US, a button marked "-" if they did not expect the stimulus to be followed by the US, or a button marked "0" if they were uncertain. For the purpose of data analysis, + was scored as +1, - were scored as -1, and 0 was scored as 0. Average expectancy ratings during the last 4 blocks of trials were used as an indicator of fear learning (greater responses to the CS+, relative to the CS-, indicated greater learning).

    Average of the ratings from trial block 13, trial block 14, trial block 15, and trial block 16 on Day 1

  • US Expectancy Ratings to CS+, CS-, and Generalization Stimuli During Generalization Testing

    Participants were exposed to 3 blocks of trials, and each block included 1 presentation of the CS+, one presentation of each of 7 generalization stimuli (GSs), and one presentation of the CS-. Participants were instructed to press, within 3 seconds of stimulus onset, a button marked "+" if they expected the stimulus to be followed by the US, a button marked "-" if they did not expect the stimulus to be followed by the US, or a button marked "0" if they were uncertain. For the purpose of data analysis, + was scored as +1, - was scored as -1, and 0 was scored as 0. Average expectancy ratings for each stimulus across all 3 blocks were used as an indicator of fear. Greater scores for the generalization stimuli (GS) indicated a greater generalization of fear.

    Average of ratings from all trials on Day 2

Secondary Outcomes (6)

  • Change in Baseline Salivary Cortisol (Nmol/l)

    Day 1 (change from baseline to 25 min post-stress)

  • Change in Baseline Salivary Alpha-amylase (U/ml)

    Day 1 (change from baseline to immediately after stress)

  • Average Subjective Pain, as Assessed by Verbal Self Report

    Stress or sham control condition on Day 1

  • Average Subjective Stress, as Assessed by Verbal Self Report

    Stress or sham control condition on Day 1

  • Change in Heart Rate (Bpm)

    Day 1 (change from baseline to during stress or sham control manipulation)

  • +1 more secondary outcomes

Other Outcomes (6)

  • Salivary Estradiol (pg/ml)

    Average across Day 1 (baseline) and Day 2 (baseline)

  • State Anxiety

    Day 2 - following generalization testing

  • Childhood Trauma Questionnaire (CTQ)

    Day 2 - following generalization testing

  • +3 more other outcomes

Study Arms (8)

Stress, immediate, males

EXPERIMENTAL

Stress immediately before learning in males

Behavioral: Stress immediately before learning in males

Stress, delayed, males

EXPERIMENTAL

Stress 30 minutes before learning in males

Behavioral: Stress 30 minutes before learning in males

Sham control, immediate, males

SHAM COMPARATOR

Sham control immediately before learning in males

Behavioral: Sham control immediately before learning in males

Sham control, delayed, males

SHAM COMPARATOR

Sham control 30 minutes before learning in males

Behavioral: Sham control 30 minutes before learning in males

Stress, immediate, females

EXPERIMENTAL

Stress immediately before learning in females

Behavioral: Stress immediately before learning in females

Stress, delayed, females

EXPERIMENTAL

Stress 30 minutes before learning in females

Behavioral: Stress 30 minutes before learning in females

Sham control, immediate, females

SHAM COMPARATOR

Sham control immediately before learning in females

Behavioral: Sham control immediately before learning in females

Sham control, delayed, females

SHAM COMPARATOR

Sham control 30 minutes before learning in females

Behavioral: Sham control 30 minutes before learning in females

Interventions

Male participants will be exposed to the socially evaluated cold pressor test immediately prior to fear learning. Participants will place their dominant hand in a bath of ice cold water for up to 3 minutes. The participants will also be informed that they are being videotaped for analysis of facial expressions and be asked to stare at a camera throughout the manipulation. Immediately following the acute stressor, participants will undergo the acquisition phase of fear conditioning.

Stress, immediate, males

Male participants will be exposed to the sham control condition (no stress) immediately prior to fear learning. Participants will place their dominant hand in a bath of lukewarm water for up to 3 minutes. Immediately following the sham control condition, participants will undergo the acquisition phase of fear conditioning.

Sham control, immediate, males

Male participants will be exposed to the socially evaluated cold pressor test 30 minutes prior to fear learning. Participants will place their dominant hand in a bath of ice cold water for up to 3 minutes. The participants will also be informed that they are being videotaped for analysis of facial expressions and be asked to stare at a camera throughout the manipulation. Thirty minutes following the acute stressor, participants will undergo the acquisition phase of fear conditioning.

Stress, delayed, males

Male participants will be exposed to the sham control condition (no stress) 30 minutes prior to fear learning. Participants will place their dominant hand in a bath of lukewarm water for up to 3 minutes. Thirty minutes following the sham control condition, participants will undergo the acquisition phase of fear conditioning.

Sham control, delayed, males

Female participants will be exposed to the socially evaluated cold pressor test immediately prior to fear learning. Participants will place their dominant hand in a bath of ice cold water for up to 3 minutes. The participants will also be informed that they are being videotaped for analysis of facial expressions and be asked to stare at a camera throughout the manipulation. Immediately following the acute stressor, participants will undergo the acquisition phase of fear conditioning.

Stress, immediate, females

Female participants will be exposed to the sham control condition (no stress) immediately prior to fear learning. Participants will place their dominant hand in a bath of lukewarm water for up to 3 minutes. Immediately following the sham control condition, participants will undergo the acquisition phase of fear conditioning.

Sham control, immediate, females

Female participants will be exposed to the socially evaluated cold pressor test 30 minutes prior to fear learning. Participants will place their dominant hand in a bath of ice cold water for up to 3 minutes. The participants will also be informed that they are being videotaped for analysis of facial expressions and be asked to stare at a camera throughout the manipulation. Thirty minutes following the acute stressor, participants will undergo the acquisition phase of fear conditioning.

Stress, delayed, females

Female participants will be exposed to the sham control condition (no stress) 30 minutes prior to fear learning. Participants will place their dominant hand in a bath of lukewarm water for up to 3 minutes. Thirty minutes following the sham control condition, participants will undergo the acquisition phase of fear conditioning.

Sham control, delayed, females

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age
  • Registered student at Ohio Northern University in Ada, Ohio

You may not qualify if:

  • Regular use of tobacco or recreational drugs (e.g., marijuana, cocaine, heroin, etc.)
  • Previous diagnosis of Raynaud's disease or peripheral vascular disease
  • Previous diagnosis of skin diseases (e.g., severe psoriasis, eczema, scleroderma)
  • History of syncope or vasovagal response to stress
  • History of any heart conditions or cardiovascular issues (e.g., high blood pressure)
  • History of severe head trauma
  • Current treatment with narcotics, beta-blockers, or steroids
  • Previous diagnosis of substance use disorder
  • Regular nightshift work
  • Hearing loss
  • Consumed alcohol in past 24 hours
  • Engaged in strenuous exercise in past 24 hours
  • Ate or drank anything but water in past 2 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ohio Northern University

Ada, Ohio, 45810, United States

Location

MeSH Terms

Conditions

Stress, PsychologicalCoitus

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorSexual Behavior

Results Point of Contact

Title
Phillip Zoladz
Organization
Ohio Northern University

Study Officials

  • Phillip Zoladz, Ph.D.

    Ohio Northern University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 18, 2018

First Posted

December 26, 2018

Study Start

January 25, 2019

Primary Completion

June 30, 2022

Study Completion

June 30, 2022

Last Updated

March 23, 2023

Results First Posted

March 23, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will share

Raw data and data from descriptive/raw measures were submitted on a semi-annual basis to the NIMH Data Archive

Time Frame
Data were shared on a semi-annual basis, beginning in January 2020.
Access Criteria
NIMH Data Archive

Locations